Publication: Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia
Issued Date
2015-05-01
Resource Type
ISSN
10969071
01466615
01466615
Other identifier(s)
2-s2.0-84925040317
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Medical Virology. Vol.87, No.5 (2015), 733-739
Suggested Citation
Jindarat Lohachanakul, Weerawat Phuklia, Montri Thannagith, Tipparat Thongsakulprasert, Duncan R. Smith, Sukathida Ubol Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia. Journal of Medical Virology. Vol.87, No.5 (2015), 733-739. doi:10.1002/jmv.24081 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/36110
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia
Other Contributor(s)
Abstract
© 2015 Wiley Periodicals, Inc. In addition to fever, rash, and arthralgia/arthritis, myalgia is another dominant symptom in Chikungunya virus (CHIKV) infection. How CHIKV induces myalgia is unclear. To better understand the viral factors involved in CHIKV-induced myalgia, CHIKVs were isolated from patients with and without myalgia designated myalgia-CHIKV and mild-CHIKV, respectively. The response of myoblasts to infection by the two groups of clinical isolates of CHIKV was investigated. Both groups of CHIKV replicated well in primary human myoblasts. However, the myalgia-CHIKVs replicated to a higher titer and caused the death of infected myoblast more rapidly than the mild-CHIKVs. CHIKV-infected myoblasts increased production of four out of five inflammatory cytokines examined (MCP-1, IP-10, MIP-1α, and IL-8) in comparison to mock-infected cells. Comparison between the myoblast inflammatory cytokine responses showed that myalgia-CHIKVs were stronger activators of cytokines than mild-CHIKVs. This means that recent epidemic strains of CHIKV exhibited different degrees of myoblast permissiveness as evidenced by differences in the ability to replicate and to stimulate inflammatory responses in myoblasts. This data suggest that the myopathic syndrome in recent epidemics is dependent upon the strain of CHIKV. J. Med. Virol. 87:733-739, 2015.